Clinical trial
A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and…
NCT00035568 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00035568 |
|---|---|
| Title | A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Non-Insulin-Dependent |
| Intervention type | Drug |
| Interventions | Glucovance (metformin HCl/glyburide), or Metformin HCl alone, or Glyburide alone. |
| Start date | Feb 1, 2002 |
| Primary completion | Jun 1, 2003 |
| Completion | Jun 1, 2003 |
| First posted | May 6, 2002 |
| Last update posted | Apr 15, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: